Biocon expands its R&D facility in Bangalore

Bio-pharma major Biocon on expansion mode.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
Real-time Stock quotes, portfolio, LIVE TV and more.
GeStepAhead SME Special
moneycontrol.com

Home » News » Business

Apr 05, 2012, 10.58 PM | Source: CNBC-TV18

Biocon expands its R&D facility in Bangalore

Bio-pharma major Biocon on expansion mode.

Like this story, share it with millions of investors on M3

Biocon expands its R&D facility in Bangalore

Bio-pharma major Biocon on expansion mode.

Post Your Comments

Share Cancel

Kiran Mazumdar-Shaw, CMD, Biocon
Bio-pharma major Biocon is on an expansion mode. The biotech major plans to invest close to Rs 100 crore on its new research and development center located in Bangalore, with a window for future investments going up to Rs 200 crore in next few years.

Biocon is banking on a strong research pipeline. The company's focus on oral insulin will continue.
 
Kiran Mazumdar-Shaw, chairman and managing director, Biocon
says, the big change in our strategy would be that from having one global partner which was Pfizer, we'll have multiple partners.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Biocon expands its R&D facility in Bangalore

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login